Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based study∗

ABSTRACT:

SUBMITTER: Trab T 

PROVIDER: S-EPMC12346063 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature